CDMO Blog

close

Subscribe to Email Updates

Popular Stories

Viral Aggregation in Downstream Processing of Lentiviral Vectors
IQ, OQ and PQ: Why Are They Important in the Manufacturing of Cell and Gene Therapies?
CDMOs: The Good, the Great and the Exceptional (and How to Tell the Difference)
Five Steps to Ensure Your Cell and Gene Therapy Product Is GMP Compliant
5 Considerations for Scaling-Up PSC-Derived Cell Therapies
21 May 2021

Scaling-Up Production of Pluripotent Stem Cells Part 1: Begin with the End in Mind

Many emerging cell and gene therapies are aimed at using cell replacem...

30 Oct 2019

Concentration and Reformulation of Cellular Immunotherapies – A Major Downstream Processing Step

Cellular immunotherapies (e.g. CAR-T cells) are primarily used as an a...

30 Oct 2019

How To Scale-Up Lentiviral Vector Production Part 2: Considerations for Downstream Processing

In Part 1 of our series on lentiviral vector (LVV) manufacturing we co...

29 Oct 2019

How to Scale-Up Lentiviral Vector Production Part 1: Considerations for Upstream Processing

Lentiviral vectors (LVV) are a key component in the production of cell...

24 Oct 2019

What is a Bioreactor and How is it Used in Cell and Gene Therapy?

Simply put, a bioreactor is a stand-alone cell culture vessel enabled ...

Tell us what you thought about this post.